Pardeep Nijhawan - 30 Jun 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Pardeep Nijhawan
Issuer symbol
EDSA
Transactions as of
30 Jun 2022
Net transactions value
+$32,078
Form type
4
Filing time
05 Jul 2022, 13:38:11 UTC
Previous filing
31 May 2022
Next filing
04 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Purchase $32,078 +20,000 +3.5% $1.60 594,812 30 Jun 2022 Direct F1
holding EDSA Common Shares 2,128,652 30 Jun 2022 Held by Pardeep Nijhawan Medicine Professional Corporation F2
holding EDSA Common Shares 224,094 30 Jun 2022 Held by The Digestive Health Clinic Inc. F2
holding EDSA Common Shares 371,727 30 Jun 2022 Held by 1968160 Ontario Inc F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.